Disoxaril

DB08726ExperimentalSmall molecule

5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. Known drug targets of 5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl...

Formula / weight: C₂₀H₂₆N₂O₃ · 342.432 g/mol (avg)
Also known as: 3-METHYL-5-(7-(P-2-OXAZOLIN-2-YLPHENOXY)HEPTYL)ISOXAZOLE · 5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole · ISOXAZOLE, 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL-
Code names: WIN-51711

Resolves to

Compound

UNIIFX8Q9PI4VPCAS87495-31-6ChEMBLCHEMBL283639ChEBI3846PubChem55717KEGGC06496

Structure

InChIKeyFKLJPTJMIBLJAV-UHFFFAOYSA-NSMILESCC1=NOC(CCCCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1

Targets

P21404Genome polyproteinP03302Genome polyproteinP03303Genome polyprotein

What you can answer from here — as of September 16, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Disoxaril, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account